|
|||||
|
|
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients |
|
| Authors: | D.J. Wojenski G.T. Bartoo J.A. Merten R.A. Dierkhising M.R. Barajas R.A. el‐Azhary J.W. Wilson M.F. Plevak W.J. Hogan M.R. Litzow M.M. Patnaik R.C. Wolf S.K. Hashmi |
| Affiliation: | 1. Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA;2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA;3. Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA;4. Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA;5. Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA |
| Abstract: | |
| Keywords: | hematopoietic stem cell transplantation immunocompromised host triazole adverse effects voriconazole cutaneous squamous cell carcinoma |